Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplantJohn J. Friedewald, Michaël Abécassis, Prabhakar K. Baliga et al.|American Journal of Transplantation|2018Cited by 156
Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant RecipientsSookhyeon Park, John J. Friedewald, Kexin Guo et al.|Clinical Journal of the American Society of Nephrology|2021Cited by 82
Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and PlatformSunil M. Kurian, Daniel R. Salomon, Eric J. Velazquez et al.|American Journal of Transplantation|2017Cited by 38